Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
07.11.2018 23:45:00

Global Radiation Oncology Market Research Report 2018 - Forecast to 2025

DUBLIN, Nov. 7, 2018 /PRNewswire/ --

The "Radiation Oncology Market Size, Share & Trends Analysis Report By Product (EBRT, Brachytherapy, SBRT), By Application, By Technology, By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global radiation oncology market size is expected to reach USD 10.1 billion by 2025 and is projected to witness a CAGR of 6.5% over the forecast period.

Rising prevalence of cancer is the primary factor responsible for substantial growth of the market for radiation oncology.

Technological advancements resulted in increased adoption of radiation oncology as primary cancer treatment. Development of compact advanced radiotherapy options such as CyberKnife, Gamma Knife, and tomotherapy are expected to complement this growth. These advanced methods pose lesser postoperative complications and faster recovery time.

Increasing per capita healthcare expenditure is also an important macroeconomic factor driving market growth. In addition, with the aid of supportive government initiatives and awareness, patients are not hesitant to opt for advanced treatment options. For instance, per capita health expenditure witnessed exponential growth of more than 55.0% from 1995 to 2014, as stated by the World Bank Group.

Further key findings from the study suggest:

  • In 2016, external beam radiation therapy (EBRT) inclusive of compact advanced radiation therapy, proton therapy, and linear accelerator (LINAC), held a lucrative share by product
  • Brachytherapy is likely to gain maximum share over the coming years owing to extensive usage for the treatment of prostate and breast cancer
  • EBRT applications for treatment of prostate, breast, lung, colorectal, head, and neck cancer dominated the market in 2016 by way of application
  • Image guided radiation therapy (IGRT) contributed to around 13.0% share in 2016 on the basis of technology. In this method, overall objective is to minimize the exposure to the healthy surrounding tissue
  • 3D-CRT technology is anticipated to witness a lucrative CAGR over the forecast period
  • North America held maximum share in global radiation oncology market in 2016. Developed health infrastructure, presence of many multinational players, and high per capita health infrastructure are the key regional growth drivers
  • Varian Medical Systems, Elekta AB, Accuray Incorporated, Ion Beam Applications SA, C.R. Bard, Inc., IsoRay, Inc., Mevion Medical Systems, Nordion (Canada) Inc., NTP, and Mallinckrodt Public Limited Company are some of the key market players

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Approaches for Market Estimation

Chapter 2. Executive Summary
2.1. Market Snapshot

Chapter 3. Radiation Oncology Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, by Factor
3.5. Industry Analysis - Porter's

Chapter 4. Radiation Oncology: Product Estimates & Trend Analysis
4.1. Radiation Oncology Market Share, 2016 & 2025
4.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following products:
4.2.1. External Beam Radiation Therapy
4.2.1.1. External beam radiation therapy market estimates and forecasts, 2014 to 2025
4.2.1.2. Electron-Emitting High-Energy Linear Accelerators (Linac)
4.2.1.2.1. Electron-Emitting High-Energy Linear Accelerators (Linac) market estimates and forecasts, 2014 to 2025
4.2.1.3. Compact Advanced Radiotherapy Systems
4.2.1.3.1. Compact advanced radiotherapy systems market estimates and forecasts, 2014 to 2025
4.2.1.3.2. Cyberknife
4.2.1.3.3. Gamma Knife
4.2.1.3.4. Tomotherapy
4.2.1.4. Proton Therapy
4.2.1.4.1. Proton therapy market estimates and forecasts, 2014 to 2025
4.2.1.4.2. Cyclotron
4.2.1.4.3. Synchrotron
4.2.2. Brachytherapy
4.2.2.1. Brachytherapy market estimates and forecasts, 2014 to 2025
4.2.2.2. Seeds
4.2.2.3. Applicators and After loaders
4.2.2.4. Electronic Brachytherapy
4.2.3. Systemic Beam Radiation Therapy
4.2.4. Other

Chapter 5. Radiation Oncology: Application Estimates & Trend Analysis
5.1. Radiation Oncology Market Share, 2016 & 2025
5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following applications:
5.2.1. External Beam Radiation Therapy
5.2.1.1. External beam radiation therapy market estimates and forecasts, 2014 to 2025
5.2.1.2. Prostate Cancer
5.2.1.3. Breast Cancer
5.2.1.4. Lung Cancer
5.2.1.5. Head and Neck Cancer
5.2.1.6. Colorectal Cancer
5.2.1.7. Others
5.2.2. Internal Beam Radiation Therapy
5.2.2.1. Internal beam radiation therapy market estimates and forecasts, 2014 to 2025
5.2.2.2. Prostate Cancer
5.2.2.3. Gynecological Cancer
5.2.2.4. Breast Cancer
5.2.2.5. Cervical Cancer
5.2.2.6. Penile Cancer
5.2.2.7. Other Cancer

Chapter 6. Radiation Oncology: Technology Estimates & Trend Analysis
6.1. Radiation Oncology Market Share, 2016 & 2025
6.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following technology:
6.2.1. External Beam Radiation Therapy
6.2.1.1. External beam radiation therapy market estimates and forecasts, 2014 to 2025
6.2.1.2. Image-Guided Radiotherapy (IGRT)
6.2.1.3. Intensity Modulated Radiotherapy (IMRT)
6.2.1.4. Stereotactic Technology
6.2.1.5. Proton Beam Therapy
6.2.1.6. 3D Conformal Radiotherapy (3D CRT)
6.2.1.7. Volumetric Modulated Arc Therapy (VMAT)
6.2.2. Brachytherapy
6.2.2.1. Brachytherapy market estimates and forecasts, 2014 to 2025
6.2.2.2. Low-Dose Rate Radiotherapy
6.2.2.3. High-Dose Rate Radiotherapy

Chapter 7. Radiation Oncology: Regional Estimates & Trend Analysis
7.1. Radiation Oncology Regional Movement Analysis & Market Share, 2016 & 2025

Chapter 8. Competitive Landscape

  • Varian Medical Systems
  • Elekta AB
  • Accuray Incorporated
  • Ion Beam Applications SA
  • C.R. Bard, Inc.
  • Isoray Medical, Inc.
  • Mevion Medical Systems, Inc.
  • Nordian Inc.
  • NTP Radioisotopes
  • Mallinckrodt Public Limited Company

For more information about this report visit https://www.researchandmarkets.com/research/df9wpd/global_radiation?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-radiation-oncology-market-research-report-2018---forecast-to-2025-300745830.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!